Exalenz Bioscience (Israel) Valuation Overview

EXEN -- Israel Stock  

ILS 792.30  18.50  2.28%

Exalenz Bioscience shows prevailing Real Value of S734.01 per share. The current price of the firm is S792.3. At this time the firm appears to be over valued. Macroaxis computes value of Exalenz Bioscience from reviewing the firm fundamentals such as Current Valuation of 235.76M, Operating Margin of (36.78)% and Shares Outstanding of 26.92M as well as analyzing its technical indicators and Probability Of Bankruptcy. In general, we advise to go long with undervalued instruments and to sell out overvalued instruments since at some point assets prices and their ongoing real values will submerge.
Horizon     30 Days    Login   to change
Exalenz Bioscience Ltd is rated # 2 in price to sales category among related companies. It is rated # 2 in beta category among related companies totaling about  0.06  of Beta per Price to Sales. The ratio of Price to Sales to Beta for Exalenz Bioscience Ltd is roughly  17.99 

Current Market Valuation

Exalenz Bioscience Valuation Boundaries

Over Valued
December 14, 2018
Market Value
Real Value
Target Odds
Exalenz Bioscience is not too risky asset. Calculation of real value of Exalenz Bioscience is based on 2 months time horizon. Increasing Exalenz Bioscience time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.
Additionally see Investing Opportunities. Please also try Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Search macroaxis.com